Alzheimer's drug gets unanimous backing of FDA panel FDA advisers unanimously voted that the drug, developed by Eli Lilly and known as donanemab, seems to be an effective treatment for certain Alzheimer's patients.

Source: ABC News June 11, 2024 07:14 UTC